Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03351998 · ClinicalTrials.gov registry record · Phase 4
Impact of Statin Therapy on Muscle Mitochondrial Function and Aerobic Capacity
A Phase 4 study, sponsored by University of Kansas Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 68
- Enrollment target
NCT03351998 is a Phase 4 study that has completed, run by University of Kansas Medical Center. The registered enrollment target is 68 participants.
The verdict
NCT03351998, a Phase 4 study, has completed, sponsored by University of Kansas Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 68 participants
- Enrollment target
Study Summary
The purpose of this study is to test how different doses of a statin, Lipitor, affect muscle health and function, and cardiovascular fitness.
Interventions
- DRUG Placebo Oral Tablet
- DRUG Lipitor 20Mg Tablet
- DRUG Lipitor 80Mg Tablet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2018-02-22 |
| Est. Completion | 2023-07-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03351998
The ClinicalTrials.gov registry entry for NCT03351998 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 68 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Kansas Medical Center, which has 408 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo Oral Tablet is the first listed.
NCT03351998 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03351998 about?
NCT03351998 is a clinical study titled "Impact of Statin Therapy on Muscle Mitochondrial Function and Aerobic Capacity". The purpose of this study is to test how different doses of a statin, Lipitor, affect muscle health and function, and cardiovascular fitness.
What is the current status of trial NCT03351998?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 68 participants. The study started on 2018-02-22. Estimated completion is 2023-07-07.
What interventions are being tested in trial NCT03351998?
The interventions under investigation include: Placebo Oral Tablet (DRUG), Lipitor 20Mg Tablet (DRUG), Lipitor 80Mg Tablet (DRUG).
Who is sponsoring clinical trial NCT03351998?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.